Wolverine Trading
DNA icon

Wolverine Trading’s Ginkgo Bioworks DNA Stock Holding History

Wolverine Trading’s Portfolio DNA Stock Details DNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$492K Buy
+37,200
New +$445K ﹤0.01% 3733
2025
Q2 		– Sell
-50,300
Closed -$308K – 4938
2025
Q1 		$308K Buy
50,300
+18,400
+58% +$187K ﹤0.01% 3493
2024
Q4 		$301K Buy
31,900
+6,700
+27% +$57.4K ﹤0.01% 4002
2024
Q3 		$204K Buy
25,200
+23,770
+1,662% +$238K ﹤0.01% 4075
2024
Q2 		$19.1K Buy
+1,430
New +$42.7K ﹤0.01% 4334
2024
Q1 		– Sell
-923
Closed -$62.4K – 4676
2023
Q4 		$62.4K Sell
923
-1,457
-61% -$89.2K ﹤0.01% 4208
2023
Q3 		$172K Buy
2,380
+1,127
+90% +$90.1K ﹤0.01% 3812
2023
Q2 		$90.7K Buy
1,253
+5
+0.4% +$296 ﹤0.01% 3802
2023
Q1 		$61K Buy
1,248
+163
+15% +$10.3K ﹤0.01% 3791
2022
Q4 		$73K Sell
1,085
-938
-46% -$86.3K ﹤0.01% 3500
2022
Q3 		$253K Buy
2,023
+388
+24% +$46.2K ﹤0.01% 3319
2022
Q2 		$164K Buy
+1,635
New +$199K ﹤0.01% 3640
2022
Q1 		– Sell
-1,510
Closed -$542K – 5609
2021
Q4 		$542K Sell
1,510
-208
-12% -$98.8K ﹤0.01% 3353
2021
Q3 		$838K Buy
+1,718
New +$836K ﹤0.01% 3234

Other funds holding DNA

Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return
ACG
Anchorage Capital Group New York $436M AUM 38.51% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
JMFC
J.M. Forbes & Co Boston, Massachusetts $1.27B AUM 26.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wolverine Trading's DNA Position: Q2 2025 in Review

Wolverine Trading sold out of Ginkgo Bioworks (DNA) in Q2 2025, closing a stake of 11,654 shares — an estimated $71.3K sold.

Wolverine Trading first reported a position in DNA in Q3 2021 and held it in 11 quarters. The position peaked at $270K in Q4 2024. 165 funds tracked by Wall St. Rank hold DNA as of Q2 2025.

  • Wolverine Trading reported no remaining Ginkgo Bioworks position as of Q2 2025 after selling out during the quarter.
  • Wolverine Trading sold 11,654 Ginkgo Bioworks shares in Q2 2025, an estimated $71.3K.
  • Wolverine Trading first reported a position in Ginkgo Bioworks in Q3 2021 and held it in 11 quarters.
  • Wolverine Trading's Ginkgo Bioworks position peaked at $270K in Q4 2024.
  • 165 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q2 2025.

Based on Wolverine Trading's 13F filing for Q2 2025, filed 18 Aug 2025.